| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 510 | 1.000 | 1.185 | 4.273 | 3.175 | 0 | 0 |
| Total Income - EUR | - | - | - | 510 | 1.000 | 1.185 | 4.273 | 3.175 | 0 | 0 |
| Total Expenses - EUR | - | - | - | 21 | 99 | 177 | 96 | 37 | 0 | 0 |
| Gross Profit/Loss - EUR | - | - | - | 489 | 901 | 1.007 | 4.177 | 3.138 | 0 | 0 |
| Net Profit/Loss - EUR | - | - | - | 474 | 871 | 971 | 4.048 | 3.042 | 0 | 0 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pharma Med Research S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 26 | 23 | 15 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 549 | 1.397 | 2.339 | 6.428 | 3.299 | 3.289 | 3.270 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 921 | 0 | 191 | 191 | 190 |
| Cash | - | - | - | 549 | 1.397 | 1.418 | 6.428 | 3.107 | 3.098 | 3.081 |
| Shareholders Funds | - | - | - | 517 | 1.378 | 2.323 | 6.320 | 3.299 | 3.289 | 3.270 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 58 | 42 | 31 | 108 | 0 | 0 | 0 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Pharma Med Research S.r.l.